MLAB
T3Mesa Laboratories, Inc.
Notes
| Date | Comment | Comment Type | Comment Sentiment | Link | IS CHANGE | Price Reaction |
|---|---|---|---|---|---|---|
| 2026-05-27 | Mesa Laboratories (MLAB) reported Q4 2026 GAAP EPS and revenue below estimates, causing a 19.5% stock drop on May 27. However, strong non-GAAP adjusted operating income significantly beat expectations, and the company reduced debt. The stock rebounded 8.2% on May 28, suggesting a mixed market perception balancing missed headline figures with underlying operational strength. | Earnings Transcript | Neutral | https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHuN7jKt84W1mSQN0cbY9T2uByW_DnNWxsFNLZufab0uuebKDDXgaIL1cJYgdbvuuTeGN7TEJn-4OuDcrVT7epk9CTn_AkLkTQ_CS-eblb4kBbVS0iFuvv8GI8Re_D6Iyb_0IgPOo6fHtlYO3gy2cgrk4BkINbu-MGrPWfcdK0uNaONrAhTaIo5M9y11kpi_0OtcRtcR7CCM3MdgF87J9jZLfZ6xd1dJGVNsQD-lqLvAszu5NR_r6KrxM4apa4= | False | N/A |